Biosimilar competition is one way to drive down drug costs for patients and increase access.
On the recordFebruary 8, 2024
Source
congress.govEditor's note · Context
Lujan advocates for biosimilar competition to lower drug costs and improve access for patients.
Share
More from Ben Ray Luján
Jun 11, 2026
For decades, Tribal communities have fought to secure water rights settlements that uphold their sovereignty and ensure access to safe, reliable water.
Jul 2, 2026
Today, the Supreme Court upheld a fundamental constitutional principle that has defined our nation for generations.
Jul 16, 2026
“Over the past several years, we’ve seen far too many reports detailing how lavish gifts and luxury travel have undermined public confidence in the Supreme Court,”
Jul 4, 2026
You have the ability to increase our nation’s housing supply and help address this crisis. With that in mind, we urge you to direct the release of these funds without any further delay.





